XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net Income (Loss) Attributable to Parent $ 150 $ 865
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent (637) (12)
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation 1,313 0
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 826 853
Adjustments to reconcile Net Income (Loss) to net cash provided by (used for) operating activities:    
Depreciation, amortization and accretion 520 552
Amortization of deferred financing costs and other non-cash interest 24 24
Stock-based compensation expense, net 55 69
Asset write-down charges 7 10
Deferred income tax (benefit) provision 1 5
Other non-cash adjustments, net (4) 12
Cash Provided by (Used in) Operating Activity, Discontinued Operation 897 830
Changes in assets and liabilities, excluding the effects of acquisitions:    
Increase (decrease) in accrued interest (84) (55)
Increase (decrease) in accounts payable 15 (22)
Increase (decrease) in other liabilities (42) (131)
Decrease (increase) in receivables 5 50
Decrease (increase) in other assets (33) (131)
Net cash provided by (used for) operating activities 2,187 2,066
Cash flows from investing activities:    
Capital expenditures (123) (124)
Payments for acquisitions, net of cash acquired 0 (8)
Other investing activities, net 5 5
Cash Provided by (Used in) Investing Activity, Discontinued Operation (687) (820)
Net cash provided by (used for) investing activities (805) (947)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 0 1,244
Principal payments on debt and other long-term obligations (89) (71)
Purchases and redemptions of long-term debt (1,200) (750)
Borrowings under revolving credit facility 900 0
Payments under revolving credit facility 0 (670)
Net issuances (repayments) under commercial paper program 605 1,312
Payments for financing costs 0 (12)
Purchases of common stock (23) (32)
Dividends/distributions paid on common stock (1,615) (2,049)
Net cash provided by (used for) financing activities (1,422) (1,028)
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents (40) 91
Effect of Exchange Rate on Cash and Cash Equivalents and Restricted Cash and Cash Equivalents 0 (1)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period [1] 295 281
Cash and cash equivalents and restricted cash and cash equivalents at end of period [1] $ 255 $ 371
[1] Inclusive of cash and cash equivalents and restricted cash and cash equivalents included in discontinued operations. See note 12.